Department of Chemistry and Biochemistry, University of California, San Diego, CA, 92093-0375, USA.
Adv Exp Med Biol. 2011;715:197-211. doi: 10.1007/978-94-007-0940-9_12.
The M protein is a major virulence factor of Streptococcus pyogenes (group A Streptococcus, GAS). This gram-positive bacterial pathogen is responsible for mild infections, such as pharyngitis, and severe invasive disease, like streptococcal toxic shock syndrome. M protein contributes to GAS virulence in multifarious ways, including blocking deposition of antibodies and complement, helping formation of microcolonies, neutralizing antimicrobial peptides, and triggering a proinflammatory and procoagulatory state. These functions are specified by interactions between M protein and many host components, especially C4BP and fibrinogen. The former interaction is conserved among many antigenically variant M protein types but occurs in a strikingly sequence-independent manner, and the latter is associated in the M1 protein type with severe invasive disease. Remarkably for a protein of such diverse interactions, the M protein has a relatively simple but nonideal α-helical coiled coil sequence. This sequence nonideality is a crucial feature of M protein. Nonideal residues give rise to specific irregularities in its coiled-coil structure, which are essential for interactions with fibrinogen and establishment of a proinflammatory state. In addition, these structural irregularities are reminiscent of those in myosin and tropomyosin, which are targets for crossreactive antibodies in patients suffering from autoimmune sequelae of GAS infection.
M 蛋白是化脓性链球菌(A 组链球菌,GAS)的主要毒力因子。这种革兰氏阳性细菌病原体可引起轻度感染,如咽炎,以及严重的侵袭性疾病,如链球菌中毒性休克综合征。M 蛋白通过多种方式有助于 GAS 的毒力,包括阻止抗体和补体的沉积、帮助微菌落的形成、中和抗菌肽以及引发促炎和促凝状态。这些功能是由 M 蛋白与许多宿主成分(特别是 C4BP 和纤维蛋白原)之间的相互作用决定的。前者的相互作用在许多抗原变异的 M 蛋白类型中是保守的,但以惊人的序列非依赖性方式发生,后者与 M1 蛋白类型与严重的侵袭性疾病有关。对于这样一种具有多种相互作用的蛋白质来说,令人惊讶的是,M 蛋白具有相对简单但不理想的 α-螺旋卷曲螺旋序列。这种序列非理想性是 M 蛋白的一个关键特征。非理想残基导致其卷曲螺旋结构中出现特定的不规则性,这对于与纤维蛋白原的相互作用以及促炎状态的建立是必不可少的。此外,这些结构不规则性让人联想到肌球蛋白和原肌球蛋白,它们是 GAS 感染后自身免疫后遗症患者的交叉反应抗体的靶标。